SLDB (Solid Biosciences) Shiller PE Ratio: (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SLDB Solid Biosciences Inc SLDB
34 GF Score
Price $9.32
! 2 Warning Signs
View Full Analysis

What is Solid Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Solid Biosciences  (NAS:SLDB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Solid Biosciences Shiller PE Ratio Related Terms


Solid Biosciences Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Solid Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solid Biosciences Shiller PE Ratio Chart

Solid Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Solid Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SLDB vs MNPR, DSGN, CLYM: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Solid Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solid Biosciences Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Solid Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Solid Biosciences's Shiller PE Ratio falls into.


SLDB
34GF Score
Solid Biosciences Inc SLDB
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solid Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Solid Biosciences's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Solid Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.38/333.9520*333.9520
=-0.380

Current CPI (Jun. 2026) = 333.9520.

Solid Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201512 0.000 236.525 0.000
201612 -3.623 241.432 -5.011
201703 -0.011 243.801 -0.015
201706 -8.821 244.955 -12.026
201709 -10.533 246.819 -14.251
201712 -6.743 246.524 -9.134
201803 -8.100 249.554 -10.839
201806 -7.800 251.989 -10.337
201809 -8.250 252.439 -10.914
201812 -9.600 251.233 -12.761
201903 -12.750 254.202 -16.750
201906 -11.400 256.143 -14.863
201909 -10.050 256.759 -13.071
201912 -9.750 256.974 -12.671
202003 -8.400 258.115 -10.868
202006 -5.850 257.797 -7.578
202009 -6.600 260.280 -8.468
202012 -4.650 260.474 -5.962
202103 -2.850 264.877 -3.593
202106 -2.550 271.696 -3.134
202109 -2.401 274.310 -2.923
202112 -2.456 278.802 -2.942
202203 -3.370 287.504 -3.914
202206 -3.330 296.311 -3.753
202209 -2.710 296.808 -3.049
202212 -0.680 296.797 -0.765
202303 -1.540 301.836 -1.704
202306 -1.250 305.109 -1.368
202309 -1.050 307.789 -1.139
202312 -1.000 306.746 -1.089
202403 -0.640 312.332 -0.684
202406 -0.610 314.175 -0.648
202409 -0.790 315.301 -0.837
202412 -1.020 315.605 -1.079
202503 -0.590 319.799 -0.616
202506 -0.420 322.561 -0.435
202509 -0.480 324.800 -0.494
202512 -0.530 324.054 -0.546
202603 -0.520 330.213 -0.526
202606 -0.380 333.952 -0.380

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Solid Biosciences Business Description

Address 500 Rutherford Avenue, Third Floor, Charlestown, MA, USA, 02129
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
34GF Score

Get the complete analysis for SLDB

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.32
Price